drugset
drugset / Trial / NCT00611923

Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder

NCT00611923 ↗

Phase 4 Completed 115 enrolled Weill Medical College of Cornell University National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effectiveness of flutamide in reducing symptoms of premenstrual dysphoric disorder.

Timeline

Start
2005-02
Primary completion
2011-06
Completion
2011-12

Outcome

Missed primary endpoint

registry analysis (unspecified test); Placebo vs Flutamide; p = 0.57; t-test, 2 sided NCT00611923 ↗

registry analysis (unspecified test); Placebo vs Flutamide; p = .27; t-test, 2 sided NCT00611923 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Flutamide Small molecule 125 mg —

Indications

premenstrual dysphoric disorder